165 related articles for article (PubMed ID: 10504146)
1. p53 induction as a genotoxic test for twenty-five chemicals undergoing in vivo carcinogenicity testing.
Duerksen-Hughes PJ; Yang J; Ozcan O
Environ Health Perspect; 1999 Oct; 107(10):805-12. PubMed ID: 10504146
[TBL] [Abstract][Full Text] [Related]
2. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
Mauthe RJ; Gibson DP; Bunch RT; Custer L
Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
[TBL] [Abstract][Full Text] [Related]
3. Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays.
Kerckaert GA; Brauninger R; LeBoeuf RA; Isfort RJ
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1075-84. PubMed ID: 8933057
[TBL] [Abstract][Full Text] [Related]
4. In Vitro-In Vivo Carcinogenicity.
Steinberg P
Adv Biochem Eng Biotechnol; 2017; 157():81-96. PubMed ID: 27506831
[TBL] [Abstract][Full Text] [Related]
5. Phenolphthalein and bisacodyl: assessment of genotoxic and carcinogenic responses in heterozygous p53 (+/-) mice and syrian hamster embryo (SHE) assay.
Stoll RE; Blanchard KT; Stoltz JH; Majeska JB; Furst S; Lilly PD; Mennear JH
Toxicol Sci; 2006 Apr; 90(2):440-50. PubMed ID: 16373391
[TBL] [Abstract][Full Text] [Related]
6. Oxymetholone: I. Evaluation in a comprehensive battery of genetic toxicology and in vitro transformation assays.
Holden HE; Studwell D; Majeska JB
Toxicol Pathol; 1999; 27(5):501-6. PubMed ID: 10528628
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals.
Isfort RJ; Kerckaert GA; LeBoeuf RA
Mutat Res; 1996 Sep; 356(1):11-63. PubMed ID: 8841474
[TBL] [Abstract][Full Text] [Related]
8. Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds.
Kerckaert GA; LeBoeuf RA; Isfort RJ
Fundam Appl Toxicol; 1996 Nov; 34(1):67-72. PubMed ID: 8937893
[TBL] [Abstract][Full Text] [Related]
9. Testing of known carcinogens and noncarcinogens in the Syrian hamster embryo (SHE) micronucleus test in vitro; correlations with in vivo micronucleus formation and cell transformation.
Fritzenschaf H; Kohlpoth M; Rusche B; Schiffmann D
Mutat Res; 1993 Sep; 319(1):47-53. PubMed ID: 7690458
[TBL] [Abstract][Full Text] [Related]
10. Alternative models for carcinogenicity testing.
Cohen SM; Robinson D; MacDonald J
Toxicol Sci; 2001 Nov; 64(1):14-9. PubMed ID: 11606797
[TBL] [Abstract][Full Text] [Related]
11. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
[TBL] [Abstract][Full Text] [Related]
12. Induction of micronuclei in Syrian hamster embryo cells: comparison to results in the SHE cell transformation assay for National Toxicology Program test chemicals.
Gibson DP; Brauninger R; Shaffi HS; Kerckaert GA; LeBoeuf RA; Isfort RJ; Aardema MJ
Mutat Res; 1997 Aug; 392(1-2):61-70. PubMed ID: 9269331
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
14. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
15. The Syrian hamster embryo cells transformation assay identifies efficiently nongenotoxic carcinogens, and can contribute to alternative, integrated testing strategies.
Benigni R; Bossa C; Tcheremenskaia O; Battistelli CL; Giuliani A
Mutat Res Genet Toxicol Environ Mutagen; 2015 Feb; 779():35-8. PubMed ID: 25813724
[TBL] [Abstract][Full Text] [Related]
16. NTP toxicology and carcinogenesiss studies of citral (microencapsulated) (CAS No. 5392-40-5) in F344/N rats and B6C3F1 mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2003 Jan; (505):1-268. PubMed ID: 12637974
[TBL] [Abstract][Full Text] [Related]
17. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
18. A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells.
Wilde EC; Chapman KE; Stannard LM; Seager AL; Brüsehafer K; Shah UK; Tonkin JA; Brown MR; Verma JR; Doherty AT; Johnson GE; Doak SH; Jenkins GJS
Arch Toxicol; 2018 Feb; 92(2):935-951. PubMed ID: 29110037
[TBL] [Abstract][Full Text] [Related]
19. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
20. Morphological transformation of Syrian hamster embryo cells by mezerein.
Tu AS; Tennant RW; Spalding JW
Cancer Lett; 1992 Feb; 62(2):159-65. PubMed ID: 1540943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
